Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001193125-26-009152

Options or other derivatives

  • General Counsel acquired 412,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DENYES NANCY General Counsel 2026-01-09 Grant or award · Employee Stock Options (right to buy) +412,500 412,500 D
Loading xslF345X05/ownership.xml…